Prentiss Smith & Co’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,107
Closed -$181K 72
2023
Q4
$181K Sell
10,107
-1,133
-10% -$20K 0.14% 66
2023
Q3
$185K Buy
+11,240
New +$204K 0.14% 64
2023
Q1
Sell
-9,431
Closed -$214K 68
2022
Q4
$214K Sell
9,431
-153
-2% -$3.46K 0.19% 59
2022
Q3
$253K Sell
9,584
-125
-1% -$3.71K 0.22% 55
2022
Q2
$240K Sell
9,709
-1,000
-9% -$25K 0.19% 61
2022
Q1
$355K Sell
10,709
-180
-2% -$5K 0.21% 60
2021
Q4
$356K Sell
10,889
-100
-0.9% -$3.4K 0.17% 67
2021
Q3
$461K Hold
10,989
0.23% 56
2021
Q2
$427K Sell
10,989
-117
-1% -$4.18K 0.21% 61
2021
Q1
$379K Sell
11,106
-670
-6% -$28.6K 0.19% 60
2020
Q4
$534K Sell
11,776
-625
-5% -$21.8K 0.25% 53
2020
Q3
$341K Buy
12,401
+18
+0.1% +$587 0.18% 56
2020
Q2
$456K Buy
12,383
+152
+1% +$5.67K 0.28% 44
2020
Q1
$396K Buy
12,231
+200
+2% +$8.33K 0.27% 48
2019
Q4
$493K Buy
12,031
+4,425
+58% +$175K 0.32% 44
2019
Q3
$271K Buy
7,606
+56
+0.7% +$2.27K 0.18% 54
2019
Q2
$388K Buy
+7,550
New +$377K 0.25% 53
2018
Q4
Sell
-670
Closed -$51K 191
2018
Q3
$51K Hold
670
0.03% 117
2018
Q2
$48K Buy
+670
New +$32K 0.03% 120

Other funds holding RGNX